期刊文献+

血清TNF-α、血管紧张素Ⅱ在CHF患者血红蛋白水平变化中的作用及其与心室重构关系的研究 被引量:3

Role of INF-α,angiotensin Ⅱ in hemoglobin concentration changes and their correlation with ventricular remodeling in patients with congestive heart failure
暂未订购
导出
摘要 目的:研究血清肿瘤坏死因子α(TNF-α)、血管紧张素Ⅱ(AngⅡ)在慢性心力衰竭(CHF)患者血红蛋白水平变化中的作用,探讨肾素-血管紧张素系统、炎症细胞因子、血红蛋白水平变化与心室重构的关系。方法:对入选的121例CHF患者测定了血红蛋白、血清TNF-α和AngⅡ水平,超声心动图测量左室射血分数(LVEF),评价心功能;计算左心室质量指数(LVMI)和室壁应力(MWS);按血红蛋白水平将CHF分为贫血组和非贫血组,同时选择27例正常人作为对照组。结果:CHF患者Hb水平低于正常对照组,而血清TNF-α和AngⅡ水平以及MWS和LVMI高于对照组(P<0.01);随着心功能恶化,Hb水平逐渐降低,而血清TNF-α和AngⅡ水平以及MWS和LVMI逐渐升高;CHF贫血组患者血清TNF-α和AngⅡ水平以及MWS和LVMI明显高于非贫血组患者(P<0.01);随着Hb水平降低,CHF患者血清TNF-α和AngⅡ水平以及MWS和LVMI明显升高(P<0.01);CHF患者MWS和LVMI与Hb水平呈负相关,与TNF-α、AngⅡ水平呈正相关(P<0.01)。结论:CHF患者TNF-α和AngⅡ水平的升高参与了CHF贫血和心室重构发生发展的病理生理过程,而CHF患者贫血的出现使CHF心室重构加重。
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2008年第6期1234-1236,共3页 Chinese Journal of Pathophysiology
基金 青海省科技厅自然科学基金资助项目(No2006-N-149)
关键词 心力衰竭 充血性 血管紧张素II 肿瘤坏死因子 心室重构 Heart failure, congestive Angiotensin II Tumor necrosis factor Ventricular remodeling
  • 相关文献

参考文献7

  • 1Haehling S, jankowska EA, Anker SD. Tumour necrosis factor - alpha and the failing heart - pathophysiology and therapeutic implications[ J ]. Basic Res Cardiol, 2004,99(1):18-28.
  • 2Dinesh K. Angiotensin Ⅱ induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein linase C - dependent pathway [ J ]. Circulation, 2002, 105(14) : 2198 -2205.
  • 3沈武忠,高广道,周佽想,刘健,林元喜.AngⅡ对成年大鼠心肌成纤维细胞分泌ET-1、NO功能的影响[J].中国病理生理杂志,2002,18(9):1050-1052. 被引量:11
  • 4陈齐红,覃数,汪华玲,肖骅.血管紧张素Ⅱ刺激心衰患者外周血单个核细胞分泌TNF-α和NO[J].中国病理生理杂志,2005,21(6):1097-1100. 被引量:12
  • 5Dominguez A,Pena J,perez M, et al. Long - term prognosis value of anemia in a non - selected population with heart failure[ J ]. Med Clin, 2007,128 (10) :370 - 371.
  • 6Devereux RB, Alonso DR, Lutos EM,et al. Echocardiographic assessment of left ventricular hypertrophy : comparison to necropsy finding [ J ]. Am J Cardiol, 1986,57(9) :450 -455.
  • 7Setsuta K, Seino Y, Ogawa T, et al. Ongoing myocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/Fas ligand system[ J]. Circ J, 2004,68(8) .747 -750.

二级参考文献13

  • 1田斌 刘健 等.血管紧张素II对细胞因子诱导一氧化氮合酶的表达引起心肌成纤维细胞凋亡的调控作用[J].中国病理生理杂志,2000,16(10):974-975.
  • 2Mckinney W. Bacterial lipopolysaccharide-stimulated realease of tumor necrosis factor-alpha from the isolated rat heart: the effect of aprotinin and forskolin[J]. Am Surg, 2003, 69(2): 131-135.
  • 3Griel B, Grossman MD, MSC, Luis E, et al. Evidence for increased peripheral production of tumor necrosis factor-α in advanced congestive heart failure[J]. Am J Cardiol, 2001, 88(9): 123-129.
  • 4Inna Frolkis. Interaction between paracrine tumor necrosis factor-α and paracrine angiotensin Ⅱ during myocardial ischemia[J]. J A Coll Cardiol, 2001, 37(2): 316-322.
  • 5Mari D, Berardino F, Cugno M. Chronic heart failure and the immune system[J]. Clin Rev Allergy Immunol, 2002, 23(3): 325-340.
  • 6Mydlowska B, Salomon P. Cytokines and remodeling of the heart in patients with congestive heart failure[J]. Pol Arch Med Wewn, 2003, 109(1): 23-33.
  • 7Tabet JY, Lopes ME, Champagne S, et al. Inflammation, cytokines and anti-inflammatory therapies in heart failure[J]. Arch Mal Coeur Vaiss, 2002, 95(3): 204-212.
  • 8Dinesh K. Angiotensin Ⅱ induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein linase C-dependent pathway[J]. Circulation, 2002, 105(14): 2198-2205.
  • 9詹昌德.一氧化氮在防止心肌肥厚反应中的作用及其机制[J].生理科学进展,2000,31(4):322-324. 被引量:43
  • 10王华,斯琴,王小明,郭恒怡,李素敏,吴其夏.血管紧张素II对血管内皮细胞三种转录因子作用的影响[J].中国病理生理杂志,2001,17(3):196-199. 被引量:6

共引文献18

同被引文献36

  • 1张金国,杨娜,王学忠,宋光耀,高东升,何华.脂联素与冠心病的相关性研究[J].中华心血管病杂志,2005,33(7):669-669. 被引量:7
  • 2Mathur A, Martin JF. Stem cell and repair of the heart [J]. Lancet, 2004, 364(9429) :183 - 192.
  • 3Thomas CV, Coker ML, Zellner JL, et al. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with endstage dilated cardiomyopathy [ J ]. Circulation, 1998, 97 ( 17 ) : 1708 - 1715.
  • 4Spinale FG, Coker ML, Heung LJ, et al. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure[J]. Circulation, 2000, 102 (16) : 1944 - 1949.
  • 5Rouet - Benzineb P, Buhler JM, Dreyfus P, et al. Altered balance between matrix gelatinases ( MMP - 2 and MMP- 9 ) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP -9 in myosin - heavy chain degradation[J]. Eur J Heart Fail, 1999, 1 (4) :337 -352.
  • 6Sawicki G, Leon H, Sawicka J, et al. Degradation of myosin light chain in isolated rat hearts subjected to ischemia -reperfusion injury: a new intracellular target for matrix metalloproteinase - 2 [ J ]. Circulation, 2005, 112 (4) : 544 - 552.
  • 7Li YY, Feng Y, McTiernan CF, et al. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices[J]. Circulation, 2001, 104(10) : 1147 - 1152.
  • 8Klotz S, Foronjy RF, Dickstein ML, et al. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross - linking and myocardial stiffness [ J ]. Circulation, 2005, 112 ( 3 ) : 364 - 374.
  • 9Lin Y, Huang R, Chen LP, et al. Profiling of cytokine expression by biotin - labeled - based protein arrays [ J ]. Proteomics, 2003, 3(9):1750-1757.
  • 10Peterson JT. The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors[J]. Cardiovasc Res, 2006, 69(3):677-687.

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部